The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...
The main issue in the recent decision was whether the orphan drug exclusivity (“ODE”) for a calcium, magnesium, potassium, and sodium oxybates drug product blocked the approval of another new drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results